May 2019CIOAPPLICATIONS.COM 19works collaboratively with biotech and clinical research organizations that are on the verge of a first product launch and ensures their products run flawlessly. We also serve chemical, agriculture and food companies that are closely intertwined with the highly regulated pharmaceutical processes.Could you share a client success story?Recently, we assisted a large pharmaceutical client to integrate with their newly acquired business. We worked on both the seller and buyer sides and delivered against the respective TSAs. The $5 billion deal posed a challenge on the buyer side due to the lack of manpower to handle large workloads, and we had to quickly integrate the new business. Our team of 35 people, highly experienced in business technology and integration, implemented a methodology tailored around M&A for the life sciences industry. We delivered a broad range of services, such as support of the transfer of market authorization numbers, optimization of distribution networks, and integration of external supply partners with the client's existing business operations. We delivered the integration faster than expected, meeting our client's budget and quality expectations. The client's newly integrated business today runs without any issues. To add to this success, the client chose to collaborate with us on our follow-up projects, which speaks volumes about the quality and the value we deliver.What does the future hold for the company?We are working, amongst other solutions, for example on a digital/e-labeling solution for clinical products that combines SAP and non-SAP technologies to rejuvenate patient experience. Apart from increased patient safety and increased efficiency in clinical development, we expect significant lead-time reductions when it comes to the distribution of clinical products. We aim to be a market leader for life sciences specific custom solutions in the near future. We recently expanded from our current offices in the US, Germany, UK, and Portugal, into AsiaPac, namely Hong Kong, Shanghai and Singapore. As a neutral, independent advisor to CIOs, Tenthpin will continue delivering the best value to our clients, with a wide range of services and solutions. We are constantly on the lookout for partnership and co-innovation opportunities with large life sciences companies and small startups, and to provide them with best-of-breed solutions. Our goal is to build sustainability and continuity in the consulting business. We recently launched a pre-configured solution for cell & gene therapies (CGTSM) that covers the whole end-to-end, patient-centric value chain with SAP S/4 HANAMichael Schmidt
< Page 9 | Page 11 >